Marina Chiara Garassino
玛丽娜·加拉西诺
MD
Professor of Medicine, Thoracic Oncology Program医学教授，胸部肿瘤项目
👥Biography 个人简介
Dr. Marina Garassino is a preeminent thoracic oncologist at the University of Chicago, formerly at Istituto Nazionale Tumori Milan. Her work spans NSCLC immunotherapy, TAPUR basket trials, and IO combination strategies, and she has led landmark trials including KEYNOTE-189. She is a global voice for immunotherapy innovation.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
NSCLC IO Combinations & TAPUR Basket Trials
Led KEYNOTE-189 subgroup analyses and TAPUR basket trial expansions in NSCLC, defining IO plus chemotherapy combinations and basket approaches for patients with actionable or immunogenic NSCLC subsets.
Representative Works 代表性著作
Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer (KEYNOTE-189)
New England Journal of Medicine (2018)
Established pembrolizumab plus pemetrexed-platinum as first-line standard for non-squamous metastatic NSCLC regardless of PD-L1 status, with sustained OS benefit at 4-year follow-up.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
关注 玛丽娜·加拉西诺 的研究动态
Follow Marina Chiara Garassino's research updates
留下邮箱，当我们发布与 Marina Chiara Garassino（University of Chicago Medicine）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment